A new study discovered that increased cardiovascular risk factors during childhood and adolescence may be associated with poorer brain function in early adulthood, according to a study published in ...

SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...

MK-0616, an experimental oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, met its primary endpoint and substantially reduced levels of low-density lipoprotein (LDL) cholesterol in ...

Patients receiving concomitant PCSK9 inhibitor therapy experienced greater LDL cholesterol reductions, exceeding 50% during ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk. Higher cholesterol variability correlates with a greater incidence of dementia ...

Despite decades of study, a pharmacopoeia of medicines, and untold millions in pharmaceutical research, heart disease remains the leading cause of death around the world. Excess cholesterol in ...

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. HealthDay News — A single combined measure of high-sensitivity C-reactive protein (CRP), low ...

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. (HealthDay News) — A single combined measure of high-sensitivity C-reactive protein (CRP), ...

Relatively little is known about the health outcomes associated with very low plasma concentrations of high-density lipoprotein cholesterol (HDL-C) mainly because of the small numbers of individuals ...

As part of "heart health month," we're looking at lipoprotein (a). For decades, doctors have encouraged patients to monitor their cholesterol levels, with studies showing that heart disease risk ...